Search Results - "José C Armario‐Hita"

Refine Results
  1. 1

    Trend of relevant contact allergens of the feet in Spain over a period of 10 years by Rodríguez‐Jiménez, Pedro, Descalzo, Miguel A., Giménez Arnau, Ana M., Silvestre, Juan F., García Gavín, Juan, Fernández Redondo, Virginia, Ruiz González, Inmaculada, Mercader García, Pedro, ArmarioHita, José C., Sánchez‐Pérez, Javier

    Published in Contact dermatitis (01-04-2020)
    “…Introduction Allergic contact dermatitis (ACD) of the feet accounts for approximately 10% of all patch tested patients. Objective To study the clinical profile…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Frontal Congenital Lipoma by Carranza‐Romero, Carmen, ArmarioHita, José C., Fernandez‐Vozmediano, José M.

    Published in Pediatric dermatology (01-07-2012)
    “…:  Frontonasal dysplasia (FND) is a rare syndrome characterized by malformations of the central portion of the face, especially of the forehead, nose, and…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Brodalumab: Efficacy, safety, and survival in mid‐term (52 weeks) on real clinical practice in Andalucia, Spain by Galan‐Gutierrez, Manuel, Font‐Ugalde, Pilar, Padilla, Laura, Hernandez‐Montoya, Carlos, Godoy, Daniel, ArmarioHita, Jose C., Ruiz‐Villaverde, Ricardo

    Published in International journal of dermatology (01-05-2023)
    “…Introduction Brodalumab is a recombinant monoclonal antibody (IgG2) that binds with high affinity to the human interleukin‐17 (IL‐17) receptor A and blocks the…”
    Get full text
    Journal Article
  8. 8

    Super responders to guselkumab treatment in moderate‐to‐severe psoriasis: a real clinical practice pilot series by Ruiz‐Villaverde, Ricardo, Rodriguez‐Fernandez‐Freire, Lourdes, ArmarioHita, Jose C., Pérez‐Gil, Amalia, Galán‐Gutiérrez, Manuel

    Published in International journal of dermatology (01-08-2022)
    “…Background The term super responders defines a subset of patients with moderate‐to‐severe psoriasis that present a rapid and higher rate of response to…”
    Get full text
    Journal Article
  9. 9

    Drug survival, discontinuation rates, and safety profile of secukinumab in real‐world patients: a 152‐week, multicenter, retrospective study by Ruiz‐Villaverde, Ricardo, Rodriguez‐Fernandez‐Freire, Lourdes, Galán‐Gutierrez, Manuel, ArmarioHIta, Jose C., Martinez‐Pilar, Leandro

    Published in International journal of dermatology (01-05-2020)
    “…Background Psoriasis is a chronic systemic disease that requires long‐term management. Despite data on follow‐up studies going back 5 years, little is known…”
    Get full text
    Journal Article
  10. 10

    Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives by Ruiz-Villaverde, Ricardo, Vasquez-Chinchay, Fiorella, Rodriguez-Fernandez-Freire, Lourdes, C. Armario-Hita, Jose, Pérez-Gil, Amalia, Galán-Gutiérrez, Manuel

    Published in Life (Basel, Switzerland) (10-09-2022)
    “…A fast skin clearance is the main goal to achieve in psoriasis treatment. Patients that present a fast and exceptional improvement with treatment are called…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Guselkumab dosing interval optimization in adult patients with moderate‐to‐severe psoriasis switching from ustekinumab by Ruiz‐Villaverde, Ricardo, Chinchay, Fiorella Vasquez, Rodriguez‐Fernandez‐Freire, Lourdes, ArmarioHita, Jose C., Pérez‐Gil, Amalia, Galán‐Gutiérrez, Manuel

    Published in Dermatologic therapy (01-11-2022)
    “…Psoriasis (PSO) is an inflammatory disease that emerges as a dysregulation of the interleukin 23 (IL23)/Th17 axis. There are many biologic alternatives to…”
    Get full text
    Journal Article
  13. 13

    Severe Atopic Dermatitis In Spain: A Real-Life Observational Study by Sicras-Mainar, Antoni, Navarro-Artieda, Ruth, Armario-Hita, José C

    Published in Therapeutics and clinical risk management (01-01-2019)
    “…To determine the epidemiology and characterize the treatment prescribed for severe atopic dermatitis (AD) in children/adults in usual clinical practice…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20